Walvax Biotechnology Co Ltd Class A 300142
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥11.12
- Day Range
- ¥11.26–12.55
- 52-Week Range
- ¥9.78–25.45
- Bid/Ask
- ¥12.26 / ¥12.27
- Market Cap
- ¥19.62 Bil
- Volume/Avg
- 65.5 Mil / 17.7 Mil
Key Statistics
- Price/Earnings (Normalized)
- 65.42
- Price/Sales
- 5.81
- Dividend Yield (Trailing)
- 0.08%
- Dividend Yield (Forward)
- 0.08%
- Total Yield
- 0.08%
Company Profile
Walvax Biotechnology Co Ltd is engaged in research and development, production and sales of vaccine products.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Mid Core
- Total Number of Employees
- 2,388
- Website
- http://www.walvax.com
Comparables
Valuation
|
Metric
|
300142
|
603896
|
002693
|
|---|---|---|---|
Price/Earnings (Normalized) | 65.42 | 18.81 | — |
Price/Book Value | 2.07 | 2.05 | 13.63 |
Price/Sales | 5.81 | 5.76 | 32.92 |
Price/Cash Flow | 18.10 | 12.20 | 1,005.34 |
Price/Earnings
300142
603896
002693
Financial Strength
|
Metric
|
300142
|
603896
|
002693
|
|---|---|---|---|
Quick Ratio | 2.51 | 3.21 | 0.56 |
Current Ratio | 2.94 | 3.70 | 1.08 |
Interest Coverage | 24.73 | 16.62 | −9.96 |
Quick Ratio
300142
603896
002693
Profitability
|
Metric
|
300142
|
603896
|
002693
|
|---|---|---|---|
Return on Assets (Normalized) | 1.93% | 7.55% | −4.80% |
Return on Equity (Normalized) | 3.16% | 11.00% | −8.30% |
Return on Invested Capital (Normalized) | 2.01% | 7.10% | −4.45% |
Return on Assets
300142
603896
002693
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Glcymllhv | Zfck | $88.3 Bil | |||
| Merck KGaA ADR
MKKGY
| Hzsbpmytx | Hwdnbvn | $78.0 Bil | |||
| Haleon PLC ADR
HLN
| Tkkxjyg | Gfxf | $48.4 Bil | |||
| Viatris Inc
VTRS
| Cqwhwksn | Kdtm | $13.8 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Fswvrcv | Jwzm | $13.5 Bil | |||
| Catalent Inc
CTLT
| Stwdkblh | Ngcfgc | $10.9 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Vhlhkybrw | Vrrvc | $3.5 Bil | |||
| Perrigo Co PLC
PRGO
| Mttfrxb | Nrqh | $3.5 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Wklbnhxbp | Dxsvj | $2.5 Bil | |||
| Curaleaf Holdings Inc
CURLF
| Lrnbwhmp | Xlty | $2.3 Bil |
United States